https://www.selleckchem.com/pr....oducts/PIK-75-Hydroc
561, 95% CI 1.182-5.55. Bilateral breast cancer had significantly shorter progression-free survival (Mean survival was 26.6 vs 52.5 months for bilateral and unilateral breast cancers, respectively; =0.001) and shorter time to develop distant metastasis (Mean survival was 41.7 vs 104 months for bilateral and unilateral breast cancers, respectively; =0.001). Patients with first primary breast tumors with lobular histological type and advanced stages were observed to have higher risks for the development of contralateral bre
Curtir
Comentario
Compartilhar
